Get all your news in one place.
100's of premium titles.
One app.
Start reading
Irish Mirror
Irish Mirror
World
Tim Hanlon & Michelle Cullen

Experimental cancer drug 'cures' every patient in trial in 'really exciting' development

Doctors have been left astonished after an experimental cancer drug proved to have a remarkable success rate.

The drug dostarlimab appeared to cure practically every patient during a clinical trial at the Memorial Sloan Kettering Cancer Center (MSKCC) in New York.

In the study, the cancer drug was given to 18 people with a type of rectal cancer every three weeks for six months.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.